Back to ProShare Advisors LLC ProShare Advisors LLC

ARWRARWR
Showing 8 of 31 quarters

Position history for ProShare Advisors LLCProShare Advisors LLC's holdings in ARROWHEAD PHARMACEUTICALS IN

ProShare Advisors LLC holds 10,434 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $850,475 as of 2026-Q2. The position was decreased (-66.9% shares). ARWR represents 0.0% of ProShare Advisors LLC's portfolio.

Current Value

$850,475

Current Shares

10,434

Total Value Change

+$166,231

Total Shares Change

-24,891

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
10,434
-66.9%
$850,4750.0%$81.51
0
2026-Q1
Decreased
31,498
-1.1%
$2M0.0%$64.10
0
2025-Q4
Increased
31,855
+13.9%
$2.1M0.0%$67.25
30
2025-Q3
Decreased
27,958
-13.1%
$964,2710.0%$33.78
0
2025-Q2
Decreased
32,176
-5.2%
$508,3810.0%$16.08
0
2025-Q1
Decreased
33,927
-25.2%
$432,2310.0%$13.82
0
2024-Q4
Increased
45,330
+28.3%
$852,2040.0%$18.61
31
2024-Q3
Increased
35,325
+21.5%
$684,2440.0%$19.67
29

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used